Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H12N2 |
Molecular Weight | 232.2799 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C3C=CC=CC3=NC2=CC4=CC=CC=C14
InChI
InChIKey=KURWKDDWCJELSV-UHFFFAOYSA-N
InChI=1S/C16H12N2/c1-18-15-9-5-2-6-11(15)10-14-16(18)12-7-3-4-8-13(12)17-14/h2-10H,1H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: DNA Sources: https://www.ncbi.nlm.nih.gov/pubmed/11543688 |
PubMed
Title | Date | PubMed |
---|---|---|
Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKα1/2-LKB1. | 2017 May 4 |
|
Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis. | 2019 May 1 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
480-26-2
Created by
admin on Fri Dec 15 17:59:29 GMT 2023 , Edited by admin on Fri Dec 15 17:59:29 GMT 2023
|
PRIMARY | |||
|
OF1UIT4RDH
Created by
admin on Fri Dec 15 17:59:29 GMT 2023 , Edited by admin on Fri Dec 15 17:59:29 GMT 2023
|
PRIMARY | |||
|
DTXSID6037645
Created by
admin on Fri Dec 15 17:59:29 GMT 2023 , Edited by admin on Fri Dec 15 17:59:29 GMT 2023
|
PRIMARY | |||
|
82143
Created by
admin on Fri Dec 15 17:59:29 GMT 2023 , Edited by admin on Fri Dec 15 17:59:29 GMT 2023
|
PRIMARY | |||
|
Cryptolepine
Created by
admin on Fri Dec 15 17:59:29 GMT 2023 , Edited by admin on Fri Dec 15 17:59:29 GMT 2023
|
PRIMARY |
METABOLITE (PARENT)
SUBSTANCE RECORD